Jynarque 90MG-30MG
Ended Awarded
- Contract number
- 36C24524N0679
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,560
Award facts
- Contract value 100% obligated
- $12,559.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. was awarded a delivery order by Veterans Integrated Service Network 5 (VISN 5) on June 21, 2024, for the supply of Jynarque (tolvaptan) in 90mg-30mg formulation. This firm fixed-price delivery order has a ceiling value of $12,559.90 and an ultimate completion date of June 24, 2024, with performance to be completed in Pittsburgh, Pennsylvania. The contract does not utilize any set-aside designations. This delivery order is issued under Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement (BPA) for Jynarque under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), which maintains an $83.3 million umbrella agreement with the Department of Veterans Affairs' National Acquisition Center.
Jynarque is a specialized pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia, representing a critical medication in the VA's pharmaceutical portfolio for veterans requiring complex medical treatment. The delivery order supports VISN 5's mission to provide healthcare services to veterans across its service area. Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer headquartered in Rockville, Maryland, has established itself as a primary supplier of this specialty pharmaceutical to the VA through multiple delivery orders across various Veterans Integrated Service Networks, demonstrating consistent capability to deliver specialized medications to federal healthcare systems.
Quick answers
Who was awarded contract 36C24524N0679?
36C24524N0679 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on June 21, 2024.
How much is contract 36C24524N0679 worth?
The government has obligated $12,560 on 36C24524N0679.
Is contract 36C24524N0679 an order under another contract?
Yes. 36C24524N0679 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0679 competed?
The extent of competition for 36C24524N0679 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award